These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 19559034)
1. Targeting pain-depressed behaviors in preclinical assays of pain and analgesia: drug effects on acetic acid-depressed locomotor activity in ICR mice. Stevenson GW; Cormier J; Mercer H; Adams C; Dunbar C; Negus SS; Bilsky EJ Life Sci; 2009 Aug; 85(7-8):309-15. PubMed ID: 19559034 [TBL] [Abstract][Full Text] [Related]
2. Targeting pain-suppressed behaviors in preclinical assays of pain and analgesia: effects of morphine on acetic acid-suppressed feeding in C57BL/6J mice. Stevenson GW; Bilsky EJ; Negus SS J Pain; 2006 Jun; 7(6):408-16. PubMed ID: 16750797 [TBL] [Abstract][Full Text] [Related]
3. Rationale and methods for assessment of pain-depressed behavior in preclinical assays of pain and analgesia. Negus SS; Bilsky EJ; Do Carmo GP; Stevenson GW Methods Mol Biol; 2010; 617():79-91. PubMed ID: 20336415 [TBL] [Abstract][Full Text] [Related]
4. Behavioral Battery for Testing Candidate Analgesics in Mice. I. Validation with Positive and Negative Controls. Diester CM; Santos EJ; Moerke MJ; Negus SS J Pharmacol Exp Ther; 2021 May; 377(2):232-241. PubMed ID: 33622770 [TBL] [Abstract][Full Text] [Related]
5. A device for automatic measurement of writhing and its application to the assessment of analgesic agents. Adachi K J Pharmacol Toxicol Methods; 1994 Oct; 32(2):79-84. PubMed ID: 7865865 [TBL] [Abstract][Full Text] [Related]
6. Changes in saccharin preference behavior as a primary outcome to evaluate pain and analgesia in acetic acid-induced visceral pain in mice. de la Puente B; Romero-Alejo E; Vela JM; Merlos M; Zamanillo D; Portillo-Salido E J Pain Res; 2015; 8():663-73. PubMed ID: 26504405 [TBL] [Abstract][Full Text] [Related]
7. Effects of pain- and analgesia-related manipulations on intracranial self-stimulation in rats: further studies on pain-depressed behavior. Pereira Do Carmo G; Stevenson GW; Carlezon WA; Negus SS Pain; 2009 Jul; 144(1-2):170-7. PubMed ID: 19435650 [TBL] [Abstract][Full Text] [Related]
8. Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine. Kaski SW; White AN; Gross JD; Trexler KR; Wix K; Harland AA; Prisinzano TE; Aubé J; Kinsey SG; Kenakin T; Siderovski DP; Setola V J Pharmacol Exp Ther; 2019 Nov; 371(2):487-499. PubMed ID: 31492823 [TBL] [Abstract][Full Text] [Related]
9. Analgesic activity of spiradoline mesylate (U-62,066E), a kappa opioid agonist in mice. Kunihara M; Ohyama M; Nakano M; Hayashi S Life Sci; 1989; 45(13):1191-8. PubMed ID: 2796604 [TBL] [Abstract][Full Text] [Related]
10. The analgesic effects and mechanisms of orally administered eugenol. Park SH; Sim YB; Lee JK; Kim SM; Kang YJ; Jung JS; Suh HW Arch Pharm Res; 2011 Mar; 34(3):501-7. PubMed ID: 21547684 [TBL] [Abstract][Full Text] [Related]
11. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential. Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307 [TBL] [Abstract][Full Text] [Related]
12. Effects of μ-opioid receptor agonists in assays of acute pain-stimulated and pain-depressed behavior in male rats: role of μ-agonist efficacy and noxious stimulus intensity. Altarifi AA; Rice KC; Negus SS J Pharmacol Exp Ther; 2015 Feb; 352(2):208-17. PubMed ID: 25406170 [TBL] [Abstract][Full Text] [Related]
13. Effects of (2R,6R)-hydroxynorketamine in assays of acute pain-stimulated and pain-depressed behaviors in mice. Hillhouse TM; Partridge KJ; Garrett PI; Honeycutt SC; Porter JH PLoS One; 2024; 19(4):e0301848. PubMed ID: 38640139 [TBL] [Abstract][Full Text] [Related]
14. Antinociceptive effects and toxicity of morphine-6-O-sulfate sodium salt in rat models of pain. Holtman JR; Crooks PA; Johnson-Hardy J; Wala EP Eur J Pharmacol; 2010 Dec; 648(1-3):87-94. PubMed ID: 20828549 [TBL] [Abstract][Full Text] [Related]
15. Effects of morphine on pain-elicited and pain-suppressed behavior in CB1 knockout and wildtype mice. Miller LL; Picker MJ; Schmidt KT; Dykstra LA Psychopharmacology (Berl); 2011 Jun; 215(3):455-65. PubMed ID: 21373789 [TBL] [Abstract][Full Text] [Related]
16. Effects of kappa opioids in an assay of pain-depressed intracranial self-stimulation in rats. Negus SS; Morrissey EM; Rosenberg M; Cheng K; Rice KC Psychopharmacology (Berl); 2010 Jun; 210(2):149-59. PubMed ID: 20101391 [TBL] [Abstract][Full Text] [Related]
17. Spinal DN-9, a Peptidic Multifunctional Opioid/Neuropeptide FF Agonist Produced Potent Nontolerance Forming Analgesia With Limited Side Effects. Wang Z; Xu B; Jiang C; Zhang T; Zhang M; Li N; Zhang Q; Xu K; Chen D; Xiao J; Fang Q J Pain; 2020; 21(3-4):477-493. PubMed ID: 31521796 [TBL] [Abstract][Full Text] [Related]
18. Morphine-induced analgesic tolerance, locomotor sensitization and physical dependence do not require modification of mu opioid receptor, cdk5 and adenylate cyclase activity. Contet C; Filliol D; Matifas A; Kieffer BL Neuropharmacology; 2008 Mar; 54(3):475-86. PubMed ID: 18082850 [TBL] [Abstract][Full Text] [Related]
19. Differential tolerance to morphine antinociception in assays of pain-stimulated vs. pain-depressed behavior in rats. Altarifi AA; Negus SS Eur J Pharmacol; 2015 Feb; 748():76-82. PubMed ID: 25530266 [TBL] [Abstract][Full Text] [Related]
20. Low-Efficacy Mu Opioid Agonists as Candidate Analgesics: Effects of Novel C-9 Substituted Phenylmorphans on Pain-Depressed Behavior in Mice. Santos EJ; Akbarali HI; Bow EW; Chambers DR; Gutman ES; Jacobson AE; Kang M; Lee YK; Lutz JA; Rice KC; Sulima A; Negus SS J Pharmacol Exp Ther; 2024 Oct; 391(2):138-151. PubMed ID: 38637015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]